and who were given a variety of live attenuated vaccinations, 3 of 17 patients developed vaccine-associated infection, and 7 of 17 patients experienced disease flares JAK inhibitors. Cutaneous vaccine-strain varicella infection developed in 1 of 55 RA patients given a single dose of the live attenuated VZV vaccine 2-3 weeks prior to tofacitinib initiation in the context of an RCT. Later testing demonstrated that the study participant lacked prevaccination immunity to VZV Intravenous